Protein family
The protein has not catalytic activity
Protein sequence
Protein function
Catalytic activity
PDB | Resolution (Å) | PDB name |
---|
GO ontology | GO term | GO description |
---|---|---|
Biological Process | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
Biological Process | GO:1990000 | amyloid fibril formation |
Biological Process | GO:0008637 | apoptotic mitochondrial changes |
Biological Process | GO:0000422 | autophagy of mitochondrion |
Biological Process | GO:0007049 | cell cycle |
Biological Process | GO:0090398 | cellular senescence |
Biological Process | GO:0051882 | mitochondrial depolarization |
Biological Process | GO:0030889 | negative regulation of B cell proliferation |
Biological Process | GO:0008285 | negative regulation of cell population proliferation |
Biological Process | GO:0033088 | negative regulation of immature T cell proliferation in thymus |
Biological Process | GO:0006469 | negative regulation of protein kinase activity |
Biological Process | GO:2000435 | negative regulation of protein neddylation |
Biological Process | GO:1903051 | negative regulation of proteolysis involved in protein catabolic process |
Biological Process | GO:1904667 | negative regulation of ubiquitin protein ligase activity |
Biological Process | GO:2000059 | negative regulation of ubiquitin-dependent protein catabolic process |
Biological Process | GO:0051444 | negative regulation of ubiquitin-protein transferase activity |
Biological Process | GO:0030575 | nuclear body organization |
Biological Process | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator |
Biological Process | GO:0045893 | positive regulation of DNA-templated transcription |
Biological Process | GO:0043065 | positive regulation of apoptotic process |
Biological Process | GO:0010628 | positive regulation of gene expression |
Biological Process | GO:1900182 | positive regulation of protein localization to nucleus |
Biological Process | GO:0033235 | positive regulation of protein sumoylation |
Biological Process | GO:1901798 | positive regulation of signal transduction by p53 class mediator |
Biological Process | GO:0045944 | positive regulation of transcription by RNA polymerase II |
Biological Process | GO:0070534 | protein K63-linked ubiquitination |
Biological Process | GO:0031648 | protein destabilization |
Biological Process | GO:1902570 | protein localization to nucleolus |
Biological Process | GO:0034504 | protein localization to nucleus |
Biological Process | GO:0000209 | protein polyubiquitination |
Biological Process | GO:0050821 | protein stabilization |
Biological Process | GO:0016925 | protein sumoylation |
Biological Process | GO:0006364 | rRNA processing |
Biological Process | GO:0010389 | regulation of G2/M transition of mitotic cell cycle |
Biological Process | GO:1902510 | regulation of apoptotic DNA fragmentation |
Biological Process | GO:0051726 | regulation of cell cycle |
Biological Process | GO:0046825 | regulation of protein export from nucleus |
Biological Process | GO:0031647 | regulation of protein stability |
Biological Process | GO:1903214 | regulation of protein targeting to mitochondrion |
Biological Process | GO:1904666 | regulation of ubiquitin protein ligase activity |
Biological Process | GO:0048103 | somatic stem cell division |
Molecular Function | GO:0003677 | DNA binding |
Molecular Function | GO:0097371 | MDM2/MDM4 family protein binding |
Molecular Function | GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding |
Molecular Function | GO:0019789 | SUMO transferase activity |
Molecular Function | GO:0097718 | disordered domain specific binding |
Molecular Function | GO:0002039 | p53 binding |
Molecular Function | GO:1990948 | ubiquitin ligase inhibitor activity |
Molecular Function | GO:0055105 | ubiquitin-protein transferase inhibitor activity |
Cellular Component | GO:0005829 | cytosol |
Cellular Component | GO:0005759 | mitochondrial matrix |
Cellular Component | GO:0005739 | mitochondrion |
Cellular Component | GO:0005730 | nucleolus |
Cellular Component | GO:0005654 | nucleoplasm |
Cellular Component | GO:0005634 | nucleus |
Cellular Component | GO:0032991 | protein-containing complex |
Reactome | Reactome Name | Node type | Reactome Root | Reactome Root Name |
---|---|---|---|---|
R-HSA-111471 | Apoptotic factor-mediated response | Internal node | R-HSA-5357801 | Programmed Cell Death |
R-HSA-2559580 | Oxidative Stress Induced Senescence | Leaf | R-HSA-8953897 | Cellular responses to stimuli |
R-HSA-2559585 | Oncogene Induced Senescence | Leaf | R-HSA-8953897 | Cellular responses to stimuli |
R-HSA-3108214 | SUMOylation of DNA damage response and repair proteins | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-3232118 | SUMOylation of transcription factors | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-6804757 | Regulation of TP53 Degradation | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-69541 | Stabilization of p53 | Internal node | R-HSA-1640170 | Cell Cycle |
R-HSA-8941858 | Regulation of RUNX3 expression and activity | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-9645722 | Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | Leaf | R-HSA-1643685 | Disease |
R-HSA-9646303 | Evasion of Oncogene Induced Senescence Due to p14ARF Defects | Leaf | R-HSA-1643685 | Disease |
R-HSA-9646304 | Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | Leaf | R-HSA-1643685 | Disease |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | Internal node | R-HSA-8953897 | Cellular responses to stimuli |
Location | ECO term | Pubmed |
---|---|---|
Mitochondrion | ECO:0000269 | PubMed:16713577 |
Nucleus, nucleolus | ECO:0000269 | PubMed:16173922 |
Nucleus, nucleolus | ECO:0000269 | PubMed:18305112 |
Nucleus, nucleolus | ECO:0000269 | PubMed:22094112 |
Nucleus, nucleolus | ECO:0000269 | PubMed:27323397 |
Nucleus, nucleoplasm | ECO:0000269 | PubMed:18305112 |
Nucleus, nucleoplasm | ECO:0000269 | PubMed:27323397 |
HPO ID | HPO name |
---|---|
HP:0000006 | Autosomal dominant inheritance |
HP:0000080 | Abnormality of reproductive system physiology |
HP:0000488 | Retinopathy |
HP:0000737 | Irritability |
HP:0000739 | Anxiety |
HP:0000819 | Diabetes mellitus |
HP:0000822 | Hypertension |
HP:0000859 | Hyperaldosteronism |
HP:0000952 | Jaundice |
HP:0000958 | Dry skin |
HP:0000975 | Hyperhidrosis |
HP:0000998 | Hypertrichosis |
HP:0001065 | Striae distensae |
HP:0001324 | Muscle weakness |
HP:0001433 | Hepatosplenomegaly |
HP:0001480 | Freckling |
HP:0001595 | Abnormal hair morphology |
HP:0001738 | Exocrine pancreatic insufficiency |
HP:0001824 | Weight loss |
HP:0001909 | Leukemia |
HP:0001939 | Abnormality of metabolism/homeostasis |
HP:0001962 | Palpitations |
HP:0002017 | Nausea and vomiting |
HP:0002027 | Abdominal pain |
HP:0002039 | Anorexia |
HP:0002071 | Abnormality of extrapyramidal motor function |
HP:0002254 | Intermittent diarrhea |
HP:0002664 | Neoplasm |
HP:0002665 | Lymphoma |
HP:0002669 | Osteosarcoma |
HP:0002716 | Lymphadenopathy |
HP:0002859 | Rhabdomyosarcoma |
HP:0002860 | Squamous cell carcinoma |
HP:0002861 | Melanoma |
HP:0002863 | Myelodysplasia |
HP:0002885 | Medulloblastoma |
HP:0002888 | Ependymoma |
HP:0002890 | Thyroid carcinoma |
HP:0002894 | Neoplasm of the pancreas |
HP:0002896 | Neoplasm of the liver |
HP:0002900 | Hypokalemia |
HP:0002910 | Elevated hepatic transaminase |
HP:0003002 | Breast carcinoma |
HP:0003003 | Colon cancer |
HP:0003110 | Abnormality of urine homeostasis |
HP:0003118 | Increased circulating cortisol level |
HP:0003418 | Back pain |
HP:0003466 | Paradoxical increased cortisol secretion on dexamethasone suppression test |
HP:0003764 | Nevus |
HP:0004324 | Increased body weight |
HP:0004389 | Intestinal pseudo-obstruction |
HP:0004396 | Poor appetite |
HP:0004808 | Acute myeloid leukemia |
HP:0005249 | Functional intestinal obstruction |
HP:0006721 | Acute lymphoblastic leukemia |
HP:0006725 | Pancreatic adenocarcinoma |
HP:0006744 | Adrenocortical carcinoma |
HP:0006753 | Neoplasm of the stomach |
HP:0007378 | Neoplasm of the gastrointestinal tract |
HP:0009592 | Astrocytoma |
HP:0009726 | Renal neoplasm |
HP:0010788 | Testicular neoplasm |
HP:0011748 | Adrenocorticotropic hormone deficiency |
HP:0012030 | Increased urinary cortisol level |
HP:0012056 | Cutaneous melanoma |
HP:0012125 | Prostate cancer |
HP:0012126 | Stomach cancer |
HP:0012142 | Pancreatic squamous cell carcinoma |
HP:0012174 | Glioblastoma multiforme |
HP:0012182 | Oropharyngeal squamous cell carcinoma |
HP:0012189 | Hodgkin lymphoma |
HP:0012288 | Neoplasm of head and neck |
HP:0012334 | Extrahepatic cholestasis |
HP:0012432 | Chronic fatigue |
HP:0012539 | Non-Hodgkin lymphoma |
HP:0025134 | Increased serum estradiol |
HP:0025269 | Panic attack |
HP:0025318 | Ovarian carcinoma |
HP:0025380 | Increased circulating androstenedione concentration |
HP:0025436 | Elevated serum 11-deoxycortisol |
HP:0030070 | Central primitive neuroectodermal tumor |
HP:0030078 | Lung adenocarcinoma |
HP:0030348 | Increased circulating androgen concentration |
HP:0030392 | Choroid plexus carcinoma |
HP:0100006 | Neoplasm of the central nervous system |
HP:0100013 | Neoplasm of the breast |
HP:0100242 | Sarcoma |
HP:0100526 | Neoplasm of the lung |
HP:0100592 | Peritoneal abscess |
HP:0100605 | Neoplasm of the larynx |
HP:0100615 | Ovarian neoplasm |
HP:0100743 | Neoplasm of the rectum |
HP:0100763 | Abnormality of the lymphatic system |
HP:0100768 | Choriocarcinoma |
HP:0200063 | Colorectal polyposis |
HP:0500022 | Abnormal circulating dehydroepiandrosterone concentration |